0001801888-20-000001.txt : 20200219 0001801888-20-000001.hdr.sgml : 20200219 20200218175727 ACCESSION NUMBER: 0001801888-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200218 EFFECTIVENESS DATE: 20200219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerflux, Inc. CENTRAL INDEX KEY: 0001801888 IRS NUMBER: 843084425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-360835 FILM NUMBER: 20626705 BUSINESS ADDRESS: STREET 1: 2140 11TH AVENUE SOUTH STREET 2: SUITE 308 CITY: BIRMINGHAM STATE: AL ZIP: 35205 BUSINESS PHONE: (855) 500-0400 X408 MAIL ADDRESS: STREET 1: 2140 11TH AVENUE SOUTH STREET 2: SUITE 308 CITY: BIRMINGHAM STATE: AL ZIP: 35205 D 1 primary_doc.xml X0708 D LIVE 0001801888 Cerflux, Inc. 2140 11TH AVENUE SOUTH SUITE 308 BIRMINGHAM AL ALABAMA 35205 (855) 500-0400 X408 DELAWARE None None Corporation true 2018 Karim I. Budhwani 232 Beaumont Drive Birmingham AL ALABAMA 35216 Executive Officer Director Dr. Budhwani is the Chief Executive Officer. Biotechnology No Revenues 06b false true false true false 25000 None None None None None None None AL ALABAMA None AL ALABAMA GA GEORGIA WA WASHINGTON false 880000 0 880000 true 0 0 0 0 No sales commissions or finder's fees will be paid. 0 No compensation will be paid to officers/directors in 2020, $90,000 will be paid to officers/directors in 2021 if operating revenue objectives are achieved, $280,000 will be paid to officers/directors in 2022. false Cerflux, Inc. C. M. Krebs C. M. Krebs CFO 2020-02-18